Randomised placebo-controlled multicentre trial to evaluate the efficacy and safety of JTR-161, allogeneic human dental pulp stem cells, in patients with Acute Ischaemic stRoke (J-REPAIR).
Satoshi SudaChikako NitoMasafumi IharaYasuyuki IguchiTakao UrabeYuji MatsumaruNobuyuki SakaiKazumi Kimuranull nullPublished in: BMJ open (2022)
NCT04608838; JapicCTI-194570 and Clinical Trials. gov.
Keyphrases
- clinical trial
- double blind
- placebo controlled
- phase ii
- phase iii
- study protocol
- stem cells
- open label
- endothelial cells
- stem cell transplantation
- randomized controlled trial
- bone marrow
- pluripotent stem cells
- induced pluripotent stem cells
- phase ii study
- cell therapy
- high dose
- squamous cell carcinoma
- hematopoietic stem cell
- locally advanced